161 related articles for article (PubMed ID: 8469622)
1. The effect of isradipine on theophylline pharmacokinetics in healthy volunteers.
Perreault MM; Kazierad DJ; Wilton JH; Izzo JL
Pharmacotherapy; 1993; 13(2):149-53. PubMed ID: 8469622
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic comparison of a once-daily and twice-daily theophylline delivery system.
González MA; Kisicki J; Straughn AB
Clin Ther; 1994; 16(4):686-92. PubMed ID: 7982257
[TBL] [Abstract][Full Text] [Related]
3. Effect of St. John's wort on the pharmacokinetics of theophylline in healthy volunteers.
Morimoto T; Kotegawa T; Tsutsumi K; Ohtani Y; Imai H; Nakano S
J Clin Pharmacol; 2004 Jan; 44(1):95-101. PubMed ID: 14681347
[TBL] [Abstract][Full Text] [Related]
4. Steady-state pharmacokinetics of a once-daily theophylline formulation (Euphylong) when given twice daily.
Götz J; Sauter R; Steinijans VW; Jonkman JH
Int J Clin Pharmacol Ther; 1994 Apr; 32(4):168-73. PubMed ID: 8032575
[TBL] [Abstract][Full Text] [Related]
5. Clopidogrel does not affect the pharmacokinetics of theophylline.
Caplain H; Thebault JJ; Necciari J
Semin Thromb Hemost; 1999; 25 Suppl 2():65-8. PubMed ID: 10440427
[TBL] [Abstract][Full Text] [Related]
6. Potential pharmacokinetic interactions of nocloprost clathrate with retarded theophylline and enteric coated diclofenac after single and repeated premedication in healthy volunteers.
Siegmund W; Scheuch E; Zschiesche M; Franke G; Stolz E; Amon I
Int J Clin Pharmacol Ther Toxicol; 1993 Aug; 31(8):407-14. PubMed ID: 8225688
[TBL] [Abstract][Full Text] [Related]
7. Effect of sucralfate on theophylline absorption in healthy volunteers.
Cantral KA; Schaaf LJ; Jungnickel PW; Monsour HP
Clin Pharm; 1988 Jan; 7(1):58-61. PubMed ID: 3345643
[TBL] [Abstract][Full Text] [Related]
8. An evaluation of the dose-dependent inhibition of CYP1A2 by rofecoxib using theophylline as a CYP1A2 probe.
Bachmann K; White D; Jauregui L; Schwartz JI; Agrawal NG; Mazenko R; Larson PJ; Porras AG
J Clin Pharmacol; 2003 Oct; 43(10):1082-90. PubMed ID: 14517190
[TBL] [Abstract][Full Text] [Related]
9. Impact of cimetidine on the pharmacokinetics of theophylline.
Schwartz JI; Bachmann KA; Bond LW; Mahajan VK
Clin Pharm; 1982; 1(6):534-8. PubMed ID: 7185539
[TBL] [Abstract][Full Text] [Related]
10. Liver dysfunction markedly decreases the inhibition of cytochrome P450 1A2-mediated theophylline metabolism by fluvoxamine.
Orlando R; Padrini R; Perazzi M; De Martin S; Piccoli P; Palatini P
Clin Pharmacol Ther; 2006 May; 79(5):489-99. PubMed ID: 16678550
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic and pharmacodynamic effects of midodrine on blood pressure, the autonomic nervous system, and plasma natriuretic peptides: a prospective, randomized, single-blind, two-period, crossover, placebo-controlled study.
Lamarre-Cliche M; Souich Pd; Champlain Jd; Larochelle P
Clin Ther; 2008 Sep; 30(9):1629-38. PubMed ID: 18840368
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and tolerability of single escalating doses of gabapentin enacarbil: a randomized-sequence, double-blind, placebo-controlled crossover study in healthy volunteers.
Lal R; Sukbuntherng J; Luo W; Chen D; Vu A; Tovera J; Cundy KC
Clin Ther; 2009 Aug; 31(8):1776-86. PubMed ID: 19808136
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic and pharmacodynamic properties of multiple oral doses of sitagliptin, a dipeptidyl peptidase-IV inhibitor: a double-blind, randomized, placebo-controlled study in healthy male volunteers.
Bergman AJ; Stevens C; Zhou Y; Yi B; Laethem M; De Smet M; Snyder K; Hilliard D; Tanaka W; Zeng W; Tanen M; Wang AQ; Chen L; Winchell G; Davies MJ; Ramael S; Wagner JA; Herman GA
Clin Ther; 2006 Jan; 28(1):55-72. PubMed ID: 16490580
[TBL] [Abstract][Full Text] [Related]
14. Effects of roxatidine acetate hydrochloride and cimetidine on the pharmacokinetics of theophylline in healthy subjects.
Yoshimura N; Takeuchi H; Ogata H; Ishioka T; Aoi R
Int J Clin Pharmacol Ther Toxicol; 1989 Jun; 27(6):308-12. PubMed ID: 2737801
[TBL] [Abstract][Full Text] [Related]
15. Nephroprotection by theophylline in patients with cisplatin chemotherapy: a randomized, single-blinded, placebo-controlled trial.
Benoehr P; Krueth P; Bokemeyer C; Grenz A; Osswald H; Hartmann JT
J Am Soc Nephrol; 2005 Feb; 16(2):452-8. PubMed ID: 15590762
[TBL] [Abstract][Full Text] [Related]
16. Bisoprolol: studies of potential interactions with theophylline and warfarin in healthy volunteers.
Warrington SJ; Johnston A; Lewis Y; Murphy M
J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S164-8. PubMed ID: 11527121
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics, pharmacodynamics, and tolerability of the dipeptidyl peptidase IV inhibitor LC15-0444 in healthy Korean men: a dose-block-randomized, double-blind, placebo-controlled, ascending single-dose, Phase I study.
Lim KS; Kim JR; Choi YJ; Shin KH; Kim KP; Hong JH; Cho JY; Shin HS; Yu KS; Shin SG; Kwon OH; Hwang DM; Kim JA; Jang IJ
Clin Ther; 2008 Oct; 30(10):1817-30. PubMed ID: 19014837
[TBL] [Abstract][Full Text] [Related]
18. Kinetic and cardiovascular comparison of immediate-release isradipine and sustained-release isradipine among non-treatment-seeking, cocaine-dependent individuals.
Johnson BA; Javors MA; Lam YW; Wells LT; Tiouririne M; Roache JD; Ait-Daoud N; Lawson K
Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jan; 29(1):15-20. PubMed ID: 15610940
[TBL] [Abstract][Full Text] [Related]
19. Effect of type II diabetes mellitus on theophylline elimination.
Adithan C; Sriram G; Swaminathan RP; Krishnan M; Bapna JS; Chandrasekar S
Int J Clin Pharmacol Ther Toxicol; 1989 May; 27(5):258-60. PubMed ID: 2737793
[TBL] [Abstract][Full Text] [Related]
20. Effects of cimetidine and ranitidine on the pharmacokinetics of a chronotherapeutically formulated once-daily theophylline preparation (Uniphyl).
Fraser IM; Buttoo KM; Walker SE; Stewart JH; Babul N
Clin Ther; 1993; 15(2):383-93. PubMed ID: 8519046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
